Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis-Reference-Cited by-同舟云学术

Identification of genetic determinants of breast cancer immune phenotypes by integrative genome-scale analysis

Published:2017-02 Issue:2 Volume:6 Page:e1253654
ISSN:2162-402X
Container-title:OncoImmunology
language:en
Short-container-title:OncoImmunology

Author:

Hendrickx Wouter¹^ORCID,Simeone Ines²³,Anjum Samreen²,Mokrab Younes⁴,Bertucci François⁵⁶⁷,Finetti Pascal⁵,Curigliano Giuseppe⁸,Seliger Barbara⁹^ORCID,Cerulo Luigi³¹⁰,Tomei Sara¹¹,Delogu Lucia Gemma¹²,Maccalli Cristina¹,Wang Ena¹¹^ORCID,Miller Lance D.¹³,Marincola Francesco M.¹⁴^ORCID,Ceccarelli Michele²,Bedognetti Davide¹^ORCID

Affiliation:

1. Tumor Biology, Immunology, and Therapy Section, Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, Doha, Qatar

2. Qatar Computing Research Institute, Hamad Bin Khalifa University, Doha, Qatar

3. Department of Science and Technology, University of Sannio, Benevento, Italy

4. Division of Biomedical Informatics, Research Branch, Sidra Medical and Research Center, Doha, Qatar

5. Département d'Oncologie Moléculaire, Center de Recherche en Cancérologie de Marseille (CRCM), Institut Paoli-Calmettes, INSERM UMR1068, CNRS UMR725, Marseille, France

6. Département d'Oncologie Médicale, CRCM, Institut Paoli-Calmettes, Marseille, France

7. Faculté de Médecine, Aix-Marseille Université, Marseille, France

8. Division of Experimental Therapeutics, Division of Medical Oncology, European Institute of Oncology, Milan, Italy

9. Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany

10. BIOGEM Research Center, Ariano Irpino, Italy

11. Division of Translational Medicine, Research Branch, Sidra Medical and Research Center, Doha, Qatar

12. Department of Chemistry and Pharmacy, University of Sassari, Sassari, Italy

13. Department of Cancer Biology, Wake Forest School of Medicine, Winston-Salem, NC, USA

14. Office of the Chief Research Officer (CRO), Research Branch, Sidra Medical and Research Center, Doha, Qatar

Publisher

Informa UK Limited

Subject

Oncology,Immunology,Immunology and Allergy

Link

https://www.tandfonline.com/doi/pdf/10.1080/2162402X.2016.1253654

Reference109 articles.

1. The immune contexture in human tumours: impact on clinical outcome

2. Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199

3. Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98

4. Tumor infiltrating lymphocytes are prognostic in triple negative breast cancer and predictive for trastuzumab benefit in early breast cancer: results from the FinHER trial

Cited by 134 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Opportunities and Challenges in Soft Tissue Sarcoma Risk Stratification in the Era of Personalised Medicine;Current Treatment Options in Oncology;2024-07-30

2. Clinical significance and immune landscape of a novel immune cell infiltration-based prognostic model in lung adenocarcinoma;Heliyon;2024-06

3. Comprehensive Analysis of Clinically Relevant Copy Number Alterations (CNAs) Using a 523-Gene Next-Generation Sequencing Panel and NxClinical Software in Solid Tumors;Genes;2024-03-23

4. Investigation of the Genomic and Transcriptomic Variations Underlying Tamoxifen Resistance in Breast Cancer;2024-03-19

5. Shifting the paradigm: engaging multicellular networks for cancer therapy;Journal of Translational Medicine;2024-03-12